Abstract. The per cent Fe59 incorporation into circulating erythrocytes as an indicator for new hemoglobin production was used in the polycythemic exhypoxic mouse system to study the effects of certain steroid hormone metabolites on erythropoiesis. Enhanced Fe59 incorporation was observed after the administration of several metabolites with a 5,3-H configuration, while those with a 5a-H configuration had no stimulatory effect. The stimulatory effect in avian systems has been shown by others to be due to an increased activity of 6-aminolevulinic acid synthetase, the limiting enzyme in heme biosynthesis. These in vivo studies thus indicate that in this mouse system, as in previously reported studies with avian and human bone marrow cells, some steroid metabolites stimulate hemoglobin synthesis. The observation that the same structure-junction relationship exists in the currently described system as in the avian suggests that these steroids probably induce 6-aminolevulinic acid synthetase in the mouse. The erythropoietic action of these nonandrogenic steroid metabolites may prove to be clinically useful.
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Recent studies by Granick and Kappas'-1 and Levere et al.4 have indicated a possible role for steroid metabolites with a 5fl-H configuration, in regulating porphyrin-heme biosynthesis via their ability to induce the de novo formation of 6-aminolevulinic acid synthetase, the rate-limiting enzyme in this pathway. The tissues in which 5-aminolevulinic acid synthetase was shown to be inducible by these steroids included the avian embryo liver and the erythroid cell precursors of the chick blastoderm. Unlike certain porphyria-inducing drugs, such as allylisopropylacetamide, which could induce 5-aminolevulinic acid synthetase in liver cell cultures but failed to do so in the chick blastoderm, the steroid metabolites were active in both tissues. A working hypothesis was presented which suggested that these metabolites may act as derepressor agents for the structural gene coding for 5-aminolevulinic acid synthetase, permitting it to transcribe more actively, leading to enhanced formation of this enzyme and thus to increased production of heme. If this formulation were correct, one could predict that these steroid metabolites might be able to regulate heme synthesis in other types of cells where 5-aminolevulinic acid synthetase was inducible such as the hepatic or erythroid tissues of other species.
It was the purpose of this study to test this question by examining the effects of various 5w-H steroid metabolites on hemoglobin synthesis in vivo in the polycythemic mouse system. In this test system hemoglobin production, as judged by Fe59 incorporation into the peripheral red cells of mice rendered polycythemic by exposure to a low oxygen tension, is essentially nil ("aplastic" phase) on days five through nine after return to ambient pressure. Such mice serve as a convenient experimental system in which to assess the erythropoietic activity of various compounds through their ability to increase labeled iron incorporation into red cells during this aplastic phase. The results of this study indicate that certain 5w-H steroid metabolites do have the ability to stimulate hemoglobin formation in mice and are thus consistent with the previously demonstrated ability of these compounds to enhance the activity of the heme-biosynthetic pathway in the hepatic and erythroid tissues of the chick embryo. 1-4 Materials and Methods. Eight to twelve week-old Swiss Webster female virgin mice weighing 19-23 gm were used in randomized groups of eight animals. Polycythemia was achieved by placing the mice in a hypobaric chamber with a constant flow of air at a fixed pressure of 340 mm Hg (altitude of 23,000 ft) for 18 days. The animals received 1-2 mg iron as iron-dextran solution intraperitoneally before entering the chamber to assure adequate iron stores. The chamber was opened for 1 hr and cages were cleaned once every 48 hr. Beginning 24 hr after removal from the chamber, three consecutive injections of the steroid metabolites were given intraperitoneally at a 48-hr interval.
2.5-3.5 mg (equivalent to 10 AM) of the steroids dissolved in 0.08 ml of 10% N,N-dimethylacetamide in propylene glycol was used in each injection. One group of mice received lithocholic acid as well, since this bile acid is known to have the potent hemolytic properties of the steroid metabolites5 but not their ability to stimulate 6-aminolevulinic acid synthetase formation.2 Twenty-four hours after the third dose of the steroid, 0.5 uCi of Fe59 citrate in 0.1 ml physiologic saline was injected into the tail vein. The Fe59 is not exchangeable with the iron present in the hemoglobin mass and is known to be incorporated only into newly formed hemoglobin. Seventy-two hours later, the animals were killed by collecting their blood from the heart. A schematic outline of the experimental protocol is shown in Figure 1 . Mice with a hematocrit of less than 55% were discarded from the study. Red blood cell radioactivity was deter-HYPOBARCHAMBER Results. Compounds with a 5,B-H configu-hormone metabolites. ration (compounds 5, 7-10) in Figure 2 produced a significant increase in Fe59 incorporation relative to the control (0.01 < p < 0.02) while those with 5a-H configuration did not. The possibility that enhanced iron incorporation is secondary to a lytic effect of the metabolites on the red cells is unlikely since no detectable decrease in the average hematocrit level of the treated group was observed with these compounds; moreover, lithocholic acid failed to produce a detectable change in the iron incorporation of the circulating erythrocytes in the concentration used in these studies (compound L, Fig. 2 diol; 6-17a-hydroxyprogesterone; 7 -17a-hydroxypregnanolone; 8-5j3-rPregnane-11, 20 dione; 9-5j3-Preg-6--~~~~~~~~~n ane~-3j3-ol-20 one; 10-5j3-Pregnane-3, 20 dione. administered in the same Mumolar dosage and according to the same protocol as the steroid metabolites is shown for comparison in Figure 2 compound D as is the response to human urinary erythropoietin (compound A, Fig. 2 ). Testosterone propionate caused an increase in iron incorporation similar to that of 17a-hydroxypregnanolone (compound 7), a nonandrogenic steroid. The system was insensitive to doses of 0.025 unit of erythropoietin; however, injecting a 0.1 unit in two doses on the third and fifth exhypoxic days resulted in about the same response as that produced by pregnandiol-3a, 20a (compound 5).
Discussion. The erythropoietic effect of androgenic steroids in mammals has been known for several years.8 The observation that some 5,3-H steroid hormone metabolites stimulated hemoglobin synthesis directly in the cultured erythroid cell precursors of the chick blastoderm4 raised the possibility that these metabolites might augment hemoglobin formation in mammals as well. The current studies indicate that certain 5,f-H steroid metabolites do have the capacity to enhance the rate of hemoglobin formation in the polycythemic mouse. Indeed the response elicited by some of these metabolites (compounds 8, 9, and 10) was greater than it was for the androgenic hormone, testosterone propionate.
Three mechanisms could account for this regulatory effect of steroid metabolites on hemoglobin synthesis in the erythropoietic cells of the mouse: (1) a direct effect on young red cell precursors, (2) an indirect effect mediated through another factor (such as erythropoietin), or (3) a combination thereof. Our system in itself cannot differentiate among these possibilities. However, evidence for the first possibility stems from the tissue culture studies described earlier4 in which erythropoietin could play no role in the effect demonstrated. These authors demonstrated significant enhancement of hemoglobin production by some steroid metabolites in the colorless proerythroblasts of the chick embryo blastoderm. The enzyme found to be ratelimiting for heme biosynthesis in these cells is 6-aminolevulinic acid synthetase.9 It was speculated that the response to steroid metabolites in these erythroid cell precursors, and in chick embryo liver cells,2 3 might be related to the ability of the compounds to derepress the structural gene coding for 6-aminolevulinic acid synthetase, resulting in increased synthesis of this enzyme and enhanced production of heme and subsequently of hemoglobin. The effect demonstrated in the chick embryo liver was not restricted to steroid metabolites of the 5fl-H configuration,2 but these compounds were more potent inducers of 5-aminolevulinic acid synthetase than were their precursor hormones. Necheles and Rai'0 recently have also demonstrated an in vitro stimulating effect of the 5f3-H steroid metabolite, etiocholanolone on heme formation in human marrow cells; they suggested that this ability of metabolites derived from androgenic hormones to regulate the differentiation of human cells into heme-synthesizing erythroid precursor cells is related to their primary effect on hemoglobin synthesis. Suggestive evidence for such a direct effect in our test system is provided by the observation that the same structurefunction relationship exists as was previously demonstrated in the avian systems.2' 4 An excellent demonstration of the importance of the configuration of the A: B ring junction of the steroid molecule in determining activity is evident by comparison of the response elicited by compounds 4 and 9 (Fig. 2) . Both have an hydroxyl group in the 3,3 configuration and a ketone at carbon 20; however, compound 4 is a 5a-H steroid and inactive, whereas compound 9 is a 5,8-H compound and has substantial activity. On the basis of these observations, one can speculate that the in vivo stimulation of erythropoiesis in our system by steroid metabolites is mediated through the same biochemical mechanism postulated earlier;'-4 i.e., via the induction of 6-aminolevulinic acid synthetase, the ratelimiting enzyme in heme formation.
These studies also suggest an additional explanation for the stimulation of erythropoiesis by exogenous androgenic steroids in man and in various experimental animals. It is possible that such stimulation is mediated in part by steroid metabolites rather than solely by the untransformed androgenic hormone. This biological action thus represents another example of the biotransformation of a parent hormone into a biologically active derivative.5 Finally these data are, from the clinical point of view, encouraging since if these compounds are active in man they would raise the possibility of the use of certain hormone metabolites for the treatment of some anemias with avoidance of the serious masculinizing side effects of the parent androgenic hormones themselves.
